Overview Executive Committee Supervisory Board Locations
Overview Satraplatin Kinase Inhibitors
Stock Major Shareholdings Key Figures Financial Reports SEC Filings

Corporate Governance

Analyst Coverage Shareholder´s Meeting Webcasts Information Request
Press Releases Contact Information
Working for GPC Biotech Germany USA

More Info

Corporate Governance Declarations

Code of Conduct

Disclosure Committee

Management and Control Structures

Compensation of the Boards

Shareholdings of the Boards

Directors' Dealings

Print preview

Back

Print

Investor Relations


Corporate Governance | Directors Dealings According to § 15 a WpHG

Emitter of Financial Instrument: GPC Biotech AG, Fraunhoferstr. 20, 82152 Martinsried

Name

Dr. Mirko Scherer (Chief Financial Officer)

Financial Instrument

Ordinary bearer shares, ISIN: DE0005851505

Classification of transaction

Purchase

Date

08/30/2007

Place

Xetra

Price

7.95

Currency

Euro

Number of shares

876

Volume

6,964.20

-

-

Name

Dr. Mirko Scherer (Chief Financial Officer)

Financial Instrument

Ordinary bearer shares, ISIN: DE0005851505

Classification of transaction

Purchase

Date

08/29/2007

Place

Xetra

Price

7.78

Currency

Euro

Number of shares

2,900

Volume

22,562.00

-

-

The below-mentioned transaction of Dr. Bernd R. Seizinger is being sold pursuant to a pre-arranged stock trading plan, designed to comply with Rule 10b5-1 of the United States Securities Exchange Act of 1934, as amended, the insider trading rules of the German Stock Trading Act (Wertpapierhandelsgesetz) and GPC Biotech AG’s insider trading policy. Under Rule 10b5-1, corporate insiders are permitted to establish a pre-arranged written stock trading plan at a time when the insider is not aware of any material non-public information (inside information). Subsequent receipt by the insider of inside information will not prevent the pre-arranged transaction under the plan from being executed. Dr. Seizinger has no control over the timing of the sales under the plan.
Dr. Seizinger entered into such a pre-arranged trading plan with CSFB International on June 15, 2007, during a trading window and at a time when he had no inside information. The plan covers a portion of Dr. Seizinger’s cash settled share options he holds under pre-existing arrangements with CSFBi. On June 15, 2007 the plan covered 6% of his entire holdings in GPC Biotech AG (including 495,000 convertible bonds with an issue date of May 31, 2007). In addition, in July Dr. Seizinger converted 49,999 convertible bonds into shares of the company which he still holds today. With the payment of the nominal amount for the 495,000 convertible bonds and the payment of the conversion price for the conversion of the 49,999 convertible bonds Dr. Seizinger has invested over EUR 1 Million (including taxes) into the Company since May 31, 2007. Future sales under the plan will continue to occur in a systematic manner with pre-determined trigger prices and with the goal of minimizing market impact by spreading such sales over a more extended period of time than would be available using traditional trading periods. All transactions under the plan will be disclosed in accordance with applicable German and US securities laws. Except as required by law, GPC Biotech AG does not undertake to report plans by other officers or directors, nor to report modifications, terminations, transactions or other activities under the plans. 

Name

Dr. Bernd R. Seizinger (Chief Executive Officer)

Financial Instrument

Cash settled stock options, ISIN: DE0005851505

Classification of transaction

Exercise and sale of stock options with strike price of EUR 3.98 ("cashless exercise via CSFBi")

Date

07/19/2007

Place

Xetra

Price

22,94

Currency

Euro

Number of shares

75,660

Volume

1,735,640.40 (actual proceeds after deduction of strike price and before tax and expense: EUR 1,434,513.60)

-

-

The transactions of Dr. Elmar Maier, Dr. Sebastian Meier-Ewert and Dr. Mirko Scherer are being made pursuant to separate pre-arranged stock trading plans, each designed to comply with Rule 10b5-1 of the United States Securities Exchange Act of 1934, as amended, the insider trading rules of the German Stock Trading Act (Wertpapierhandelsgesetz) and GPC Biotech AG’s insider trading policy. Under Rule 10b5-1, corporate insiders are permitted to establish a pre-arranged written stock trading plan at a time when the insider is not aware of any material non-public information (inside information). Subsequent receipt by the insider of inside information will not prevent the pre-arranged transaction under the plan from being executed. Dr. Maier, Dr. Meier-Ewert and Dr. Mirko Scherer have no control over the timing of the sales under the plans. Dr. Maier and Dr. Meier-Ewert entered into such pre-arranged trading plans with UBS AG on March 19, 2007, Dr. Mirko Scherer on March 29, 2007, during a trading window and at a time when they had no inside information. On March 19, 2007 the plans covered 21% and 13,7%, respectively, of Dr. Maier’s, Dr. Meier-Ewert’s and on March 29, 2007 22% of Dr. Mirko Scherer's entire holdings in GPC Biotech AG. Future sales under the plans will continue to occur in a systematic manner with pre-determined trigger prices and with the goal of minimizing market impact by spreading such sales over a more extended period of time than would be available using traditional trading periods. All transactions under the plans will be disclosed in accordance with applicable German and US securities laws. Except as required by law, GPC Biotech AG does not undertake to report plans by other officers or directors, nor to report modifications, terminations, transactions or other activities under the plans.

-

-

Name

Dr. Mirko Scherer (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 4.96 ("cashless exercise")

Date

07/13/2007

Place

Xetra

Price

22.50

Currency

Euro

Number of shares

26,916

Volume

605,610.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 472,106.64)

-

-

Name

Dr. Mirko Scherer (Member of Management Board)

Financial Instrument

Cash settled stock options, ISIN: DE0005851505

Classification of transaction

Exercise and sale of stock options with strike price of EUR 9.33 ("cashless exercise")

Date

07/13/2007

Place

Xetra

Price

22.80

Currency

Euro

Number of shares

12,500

Volume

285,000.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 168,375.00)

-

-

Name

Dr. Mirko Scherer (Member of Management Board)

Financial Instrument

Cash settled stock options, ISIN: DE0005851505

Classification of transaction

Exercise and sale of stock options with strike price of EUR 9.33 ("cashless exercise")

Date

06/29/2007

Place

Xetra

Price

20.90 (average)

Currency

Euro

Number of shares

12,500

Volume

261,250.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 144,625.00)

-

-

Name

Dr. Mirko Scherer (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 4.87 ("cashless exercise")

Date

05/31/2007

Place

Xetra

Price

21.90 (average)

Currency

Euro

Number of shares

9,084

Volume

198,939.60 (actual proceeds after deduction of strike price and before tax and expense: EUR 154,700.52)

-

-

Name

Dr. Mirko Scherer (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 4.36 ("cashless exercise")

Date

05/30/2007

Place

Xetra

Price

21.20 (average)

Currency

Euro

Number of shares

6,250

Volume

132,500 (actual proceeds after deduction of strike price and before tax and expense: EUR 105,250)

-

-

Name

Dr. Mirko Scherer (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 2.70 ("cashless exercise")

Date

05/29/2007

Place

Xetra

Price

21.356 (average)

Currency

Euro

Number of shares

10,000

Volume

213,560 (actual proceeds after deduction of strike price and before tax and expense: EUR 186,560)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 10.90 ("cashless exercise")

Date

06/15/2007

Place

Xetra

Price

20.06 (average)

Currency

Euro

Number of shares

11,250

Volume

225,675 (actual proceeds after deduction of strike price and before tax and expense: EUR 103,050)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 10.90 ("cashless exercise")

Date

06/15/2007

Place

Xetra

Price

20.05 (average)

Currency

Euro

Number of shares

9.996

Volume

200,468.78 (actual proceeds after deduction of strike price and before tax and expense: EUR 91,512,38)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 10.90 ("cashless exercise")

Date

06/12/2007

Place

Xetra

Price

20.09 (average)

Currency

Euro

Number of shares

1.254

Volume

25.197,88 (actual proceeds after deduction of strike price and before tax and expense: EUR 11,529.28)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds, ISIN: DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 10.90 ("cashless exercise")

Date

05/25/2007

Place

Xetra

Price

21.63 (average)

Currency

Euro

Number of shares

11,250

Volume

243,371.25 (actual proceeds after deduction of strike price and before tax and expense: EUR 120,746.25)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 4.96 ("cashless exercise")

Date

05/24/2007

Place

Xetra

Price

21.75 (average)

Currency

Euro

Number of shares

6,729

Volume

146,381.32 (actual proceeds after deduction of strike price and before tax and expense: EUR 113,005.48)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 4.87 ("cashless exercise")

Date

05/24/2007

Place

Xetra

Price

21.75 (average)

Currency

Euro

Number of shares

2,271

Volume

49,402.88 (actual proceeds after deduction of strike price and before tax and expense: EUR 38,343.11)

-

-

Name

Dr. Elmar Maier (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 10.90 ("cashless exercise")

Date

05/24/2007

Place

Xetra

Price

21.33 (average)

Currency

Euro

Number of shares

11,250

Volume

239,973.75 (actual proceeds after deduction of strike price and before tax and expense: EUR 117,348.75)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled stock options, ISIN: DE0005851505

Classification of transaction

Exercise and sale of stock options with strike price of EUR 5.24 ("cashless exercise")

Date

06/20/2007

Place

Xetra

Price

19.91 (average)

Currency

Euro

Number of shares

2,500

Volume

49,775.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 36,675.00)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled stock options, ISIN: DE0005851505

Classification of transaction

Exercise and sale of stock options with strike price of EUR 5.24 ("cashless exercise")

Date

06/19/2007

Place

Xetra

Price

19.91 (average)

Currency

Euro

Number of shares

5,000

Volume

99,550.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 73,350.00)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled stock options, ISIN: DE0005851505

Classification of transaction

Exercise and sale of stock options with strike price of EUR 5.24 ("cashless exercise")

Date

06/18/2007

Place

Xetra

Price

20.22 (average)

Currency

Euro

Number of shares

5,000

Volume

101,100.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 74,900.00)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 2.70 ("cashless exercise")

Date

05/24/2007

Place

Xetra

Price

21.00 (average)

Currency

Euro

Number of shares

1,750

Volume

36,750.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 32,025.00)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 2.70 ("cashless exercise")

Date

05/23/2007

Place

Xetra

Price

21.13 (average)

Currency

Euro

Number of shares

6,500

Volume

137,345.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 119,795.00)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 2.70 ("cashless exercise")

Date

05/22/2007

Place

Xetra

Price

20.56 (average)

Currency

Euro

Number of shares

6,500

Volume

133,640.00 (actual proceeds after deduction of strike price and before tax and expense: EUR 116,090.00)

-

-

Name

Dr. Sebastian Meier-Ewert (Member of Management Board)

Financial Instrument

Cash settled convertible bonds

ISIN

DE0005851505

Classification of transaction

Exercise and sale of convertible bonds with strike price of EUR 2.70 ("cashless exercise")

Date

05/21/2007

Place

Xetra

Price

20.12 (average)

Currency

Euro

Number of shares

6,500

Volume

130,773.50 (actual proceeds after deduction of strike price and before tax and expense: EUR 113,223.50)

-

-

Transactions December 2005, January 2006

 Acrobat Reader Document, approx. 0.06 MB

 

Transactions September/October 2006

 Acrobat Reader Document, approx. 0.09 MB

 

Transactions December 2006, January 2007

 Acrobat Reader Document, approx. 0.08 MB 
Investor Relations | Corporate Governance